RxFinder.ai

Ledipasvir and Sofosbuvir

Harvoni

Hepatitis C Virus NS5A Inhibitor

NADAC/unit N/A
No Shortage Tier 1: 22.5% PA Req: 104.9%

Generic Manufacturers

GILEAD SCIENCES INC

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.